Stroke Risk and Antithrombotic Treatment During the Follow-Up of Patients With Ischemic Stroke and Cortical Superficial Siderosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis
Neurology 2022 Dec 19;[EPub Ahead of Print], J Martí-Fàbregas, P Camps-Renom, JG Best, A Ramos-Pachon, M Guasch-Jiménez, A Martinez-Domeño, D Guisado-Alonso, BM Gómez-Ansón, G Ambler, D Wilson, KJ Lee, JS Lim, HJ Bae, M Shiozawa, M Koga, K Toyoda, MG Hennerici, H Chabriat, E Jouvent, DY Kwun Wong, H Mak, KK Lau, YD Kim, TJ Song, JH Heo, S Eppinger, T Gattringer, E Uysal, DS Demirelli, N Bornstein, E Ben Assayag, H Hallevi, JA Molad, M Nishihara, J Tanaka, H Hara, Y Yakushiji, SB Coutts, E Smith, AA Polymeris, B Wagner, D Seiffge, PA Lyrer, N Peters, ST Engelter, R Al-Shahi Salman, HR Jäger, GYH Lip, M Goeldlin, L Panos, CC Karayiannis, TG Phan, VK Srikanth, N Christ, S Gunkel, F Fluri, TW Leung, YOY Soo, W Chu, J Abrigo, C Barbato, S Browning, R Simister, AM Mendyk, R Bordet, S Hilal, B Gyanwali, C Chen, S Jung, DN Orken, D Werring, L Prats-SanchezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.